Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection
Background The degree of myocardial injury, as reflected by troponin elevation, and
associated outcomes among US hospitalized patients with coronavirus disease-2019 (COVID-19) …
associated outcomes among US hospitalized patients with coronavirus disease-2019 (COVID-19) …
Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute …
A Lala, SE McNulty, RJ Mentz, SM Dunlay… - Circulation: Heart …, 2015 - Am Heart Assoc
Background— Congestion is the most frequent cause for hospitalization in acute decompensated
heart failure. Although decongestion is a major goal of acute therapy, it is unclear how …
heart failure. Although decongestion is a major goal of acute therapy, it is unclear how …
Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19
Please note: This work was supported by U54 TR001433-05, National Center for Advancing
Translational Sciences, National Institutes of Health. Dr. Fayad has received consulting fees …
Translational Sciences, National Institutes of Health. Dr. Fayad has received consulting fees …
[HTML][HTML] AKI in hospitalized patients with COVID-19
Background Early reports indicate that AKI is common among patients with coronavirus
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute …
…, WK Cornwell III, KG Harmon, JH Kim, A Lala… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
Use of cardiopulmonary stress testing for patients with unexplained dyspnea post–coronavirus disease
DM Mancini, DL Brunjes, A Lala, MG Trivieri… - Heart Failure, 2021 - jacc.org
Objectives The authors used cardiopulmonary exercise testing (CPET) to define unexplained
dyspnea in patients with post-acute sequelae of severe acute respiratory syndrome-…
dyspnea in patients with post-acute sequelae of severe acute respiratory syndrome-…
Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study
…, A Badami, JD Goldman, A Lala… - Clinical Infectious …, 2021 - academic.oup.com
Background The coronavirus disease 2019 (COVID-19) pandemic has led to significant
reductions in transplantation, motivated in part by concerns of disproportionately more severe …
reductions in transplantation, motivated in part by concerns of disproportionately more severe …
Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19
GN Nadkarni, A Lala, E Bagiella, HL Chang… - Journal of the American …, 2020 - jacc.org
Background Thromboembolic disease is common in coronavirus disease-2019 (COVID-19).
There is limited evidence on the association of in-hospital anticoagulation (AC) with …
There is limited evidence on the association of in-hospital anticoagulation (AC) with …
Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction
…, C Varley, PR Moreno, VM Abascal, A Lala… - Journal of the American …, 2021 - jacc.org
Background Large clinical trials established the benefits of sodium-glucose cotransporter 2
inhibitors in patients with diabetes and with heart failure with reduced ejection fraction (HFrEF…
inhibitors in patients with diabetes and with heart failure with reduced ejection fraction (HFrEF…
Prognostic impact of prior heart failure in patients hospitalized with COVID-19
Background Patients with pre-existing heart failure (HF) are likely at higher risk for adverse
outcomes in coronavirus disease-2019 (COVID-19), but data on this population are sparse. …
outcomes in coronavirus disease-2019 (COVID-19), but data on this population are sparse. …